Analyst Ratings for Hepion Pharma (HEPA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/7/2023 | Brookline Capital Markets | Kumaraguru Raja | Downgrade | Hold (Buy) |
N/A (N/A) |
3.24 (0.32) |
-90.12% | Details |
| 2/28/2022 | Cantor Fitzgerald | Kristen Kluska | New Coverage | Overweight (N/A) |
3.50 (N/A) |
1.03 (0.32) |
-68.93% | Details |
 |
||||||||
